BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22626820)

  • 21. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent.
    Raychaudhuri S; Ripke S; Li M; Neale BM; Fagerness J; Reynolds R; Sobrin L; Swaroop A; Abecasis G; Seddon JM; Daly MJ
    Nat Genet; 2010 Jul; 42(7):553-5; author reply 555-6. PubMed ID: 20581873
    [No Abstract]   [Full Text] [Related]  

  • 22. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2008 Apr; 17(7):971-7. PubMed ID: 18084039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases.
    Hamza A; El-Sissy C; Yousfi N; Martins PV; Rafat C; Masliah-Planchon J; Frémeaux-Bacchi V; Mesnard L
    Eur J Hum Genet; 2023 Jul; 31(7):730-732. PubMed ID: 37032353
    [No Abstract]   [Full Text] [Related]  

  • 24. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
    Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
    Józsi M; Licht C; Strobel S; Zipfel SL; Richter H; Heinen S; Zipfel PF; Skerka C
    Blood; 2008 Feb; 111(3):1512-4. PubMed ID: 18006700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
    Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
    Front Immunol; 2018; 9():848. PubMed ID: 29740447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of plasma CFHR 1-5 in lupus nephropathy.
    Hu X; Liu H; Du J; Chen Y; Yang M; Xie Y; Chen J; Yan S; Ouyang S; Gong Z
    Immunobiology; 2019 May; 224(3):339-346. PubMed ID: 30975435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab.
    Nozawa A; Ozeki M; Hori T; Kawamoto N; Hirayama M; Azuma E; Fukao T
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):e544-e546. PubMed ID: 28991129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
    Tortajada A; Yébenes H; Abarrategui-Garrido C; Anter J; García-Fernández JM; Martínez-Barricarte R; Alba-Domínguez M; Malik TH; Bedoya R; Cabrera Pérez R; López Trascasa M; Pickering MC; Harris CL; Sánchez-Corral P; Llorca O; Rodríguez de Córdoba S
    J Clin Invest; 2013 Jun; 123(6):2434-46. PubMed ID: 23728178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of CFH polymorphisms and CFHR1-CFHR3 deletion with blood pressure and hypertension in Chinese population.
    Gan W; Wu J; Lu L; Xiao X; Huang H; Wang F; Zhu J; Sun L; Liu G; Pan Y; Li H; Lin X; Chen Y
    PLoS One; 2012; 7(7):e42010. PubMed ID: 22848687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of CFH Y402H polymorphism and CFHR3/CFHR1 deletion in age-related macular degeneration patients from Brazil.
    Dezidério Sacconi DP; Cabral de Vasconcellos JP; Endo Hirata F; MacCord Medina F; Rim PH; Barbosa de Melo M
    Ophthalmic Genet; 2016 Dec; 37(4):459-461. PubMed ID: 26942649
    [No Abstract]   [Full Text] [Related]  

  • 32. Genome-wide association study identifies susceptibility loci for IgA nephropathy.
    Gharavi AG; Kiryluk K; Choi M; Li Y; Hou P; Xie J; Sanna-Cherchi S; Men CJ; Julian BA; Wyatt RJ; Novak J; He JC; Wang H; Lv J; Zhu L; Wang W; Wang Z; Yasuno K; Gunel M; Mane S; Umlauf S; Tikhonova I; Beerman I; Savoldi S; Magistroni R; Ghiggeri GM; Bodria M; Lugani F; Ravani P; Ponticelli C; Allegri L; Boscutti G; Frasca G; Amore A; Peruzzi L; Coppo R; Izzi C; Viola BF; Prati E; Salvadori M; Mignani R; Gesualdo L; Bertinetto F; Mesiano P; Amoroso A; Scolari F; Chen N; Zhang H; Lifton RP
    Nat Genet; 2011 Mar; 43(4):321-7. PubMed ID: 21399633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.
    Holmes LV; Strain L; Staniforth SJ; Moore I; Marchbank K; Kavanagh D; Goodship JA; Cordell HJ; Goodship TH
    PLoS One; 2013; 8(4):e60352. PubMed ID: 23613724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in complement factor H affects complement activation in immunoglobulin A vasculitis with nephritis.
    Jia M; Zhu L; Zhai YL; Chen P; Xu BY; Guo WY; Shi SF; Liu LJ; Lv JC; Zhang H
    Nephrology (Carlton); 2020 Jan; 25(1):40-47. PubMed ID: 30838755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement factor H related proteins in immune diseases.
    Skerka C; Zipfel PF
    Vaccine; 2008 Dec; 26 Suppl 8():I9-14. PubMed ID: 19388158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3).
    Koziolek MJ; Zipfel PF; Skerka C; Vasko R; Gröne EF; Müller GA; Strutz F
    Kidney Int; 2008 Aug; 74(3):384-8. PubMed ID: 18449173
    [No Abstract]   [Full Text] [Related]  

  • 38. Is complement factor H a susceptibility factor for IgA nephropathy?
    Edey M; Strain L; Ward R; Ahmed S; Thomas T; Goodship TH
    Mol Immunol; 2009 Apr; 46(7):1405-8. PubMed ID: 19162324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carfilzomib-induced aHUS responds to early eculizumab and may be associated with heterozygous
    Portuguese AJ; Lipe B
    Blood Adv; 2018 Dec; 2(23):3443-3446. PubMed ID: 30518536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human C3 glomerulopathy provides unique insights into complement factor H-related protein function.
    Holers VM
    J Clin Invest; 2013 Jun; 123(6):2357-60. PubMed ID: 23728171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.